| A guide to therapeutic drug monitoring of β‐lactam antibiotics AJ Fratoni, DP Nicolau, JL Kuti Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 41 (2 …, 2021 | 78 | 2021 |
| Rivaroxaban vs. warfarin and renal outcomes in non-valvular atrial fibrillation patients with diabetes AV Hernandez, G Bradley, M Khan, A Fratoni, A Gasparini, YM Roman, ... European Heart Journal-Quality of Care and Clinical Outcomes 6 (4), 301-307, 2020 | 62 | 2020 |
| Levofloxacin pharmacodynamics against Stenotrophomonas maltophilia in a neutropenic murine thigh infection model: implications for susceptibility breakpoint … AJ Fratoni, DP Nicolau, JL Kuti Journal of Antimicrobial Chemotherapy 77 (1), 164-168, 2022 | 16 | 2022 |
| Minocycline pharmacodynamics against Stenotrophomonas maltophilia in the neutropenic murine infection model: implications for susceptibility breakpoints AJ Fratoni, DP Nicolau, JL Kuti Journal of Antimicrobial Chemotherapy 77 (4), 1052-1060, 2022 | 15 | 2022 |
| Imipenem/cilastatin/relebactam pharmacokinetics in critically ill patients with augmented renal clearance AJ Fratoni, JW Mah, DP Nicolau, JL Kuti Journal of Antimicrobial Chemotherapy 77 (11), 2992-2999, 2022 | 12 | 2022 |
| Optimised cefiderocol exposures in a successfully treated critically ill patient with polymicrobial Stenotrophomonas maltophilia bacteraemia and pneumonia receiving continuous … AJ Fratoni, JL Kuti, DP Nicolau International Journal of Antimicrobial Agents 58 (3), 106395-106395, 2021 | 12 | 2021 |
| Omadacycline pharmacokinetics and soft-tissue penetration in diabetic patients with wound infections and healthy volunteers using in vivo microdialysis CM Gill, AJ Fratoni, AK Shepard, JL Kuti, DP Nicolau Journal of Antimicrobial Chemotherapy 77 (5), 1372-1378, 2022 | 6 | 2022 |
| A Retrospective Case Series of Concomitant Carbapenem and Valproic Acid Use: Are Best Practice Advisories Working? AJ Fratoni, JL Colmerauer, KE Linder, DP Nicolau, JL Kuti Journal of Pharmacy Practice 36 (3), 537-541, 2023 | 3 | 2023 |
| Pharmacokinetics and soft-tissue distribution of tebipenem pivoxil hydrobromide using microdialysis: a study in healthy subjects and patients with diabetic foot infections Y Abouelhassan, AJ Fratoni, AK Shepard, DP Nicolau, TE Asempa Journal of Antimicrobial Chemotherapy 78 (1), 296-301, 2023 | 3 | 2023 |
| In vivo pharmacokinetics and pharmacodynamics of ceftibuten/ledaborbactam, a novel oral β-lactam/β-lactamase inhibitor combination AJ Fratoni, LM Avery, DP Nicolau, TE Asempa Journal of Antimicrobial Chemotherapy 78 (1), 93-100, 2023 | 3 | 2023 |
| Imipenem/funobactam (formerly XNW4107) in vivo pharmacodynamics against serine carbapenemase-producing Gram-negative bacteria: a novel modelling … AJ Fratoni, AV Berry, X Liu, X Chen, Y Wu, DP Nicolau, K Abdelraouf Journal of Antimicrobial Chemotherapy 78 (9), 2343-2353, 2023 | 2 | 2023 |
| 1087. Imipenem-Cilastatin-Relebactam (I/R) Pharmacokinetics (PK) in Critically Ill Patients with Augmented Renal Clearance (ARC) AJ Fratoni, JW Mah, DP Nicolau, JL Kuti Open Forum Infectious Diseases 8 (Suppl 1), S635, 2021 | 2 | 2021 |
| Non-KPC Attributes of Newer β-lactamase/β-lactamase Inhibitors, Part 1: Enterobacterales and Pseudomonas aeruginosa AJ Fratoni, ML Gethers, DP Nicolau, JL Kuti Clinical Infectious Diseases, ciae048, 2024 | 1 | 2024 |
| Effects of clinically achievable pulmonary antibiotic concentrations on the recovery of bacteria: in vitro comparison of the BioFire FILMARRAY Pneumonia Panel … AJ Fratoni, AL Roberts, DP Nicolau, JL Kuti Journal of Clinical Microbiology 62 (1), e01133-23, 2024 | 1 | 2024 |
| 1103. Minocycline (MIN) Pharmacodynamics (PD) against Stenotrophomonas maltophilia (STM) in a Neutropenic Murine Thigh Infection Model AJ Fratoni, DP Nicolau, JL Kuti Open Forum Infectious Diseases 8 (Suppl 1), 643, 2021 | 1 | 2021 |
| Imipenem/relebactam pharmacokinetics in critically ill patients supported on extracorporeal membrane oxygenation AJ Fratoni, AK Kois, JA Gluck, DP Nicolau, JL Kuti Journal of Antimicrobial Chemotherapy 79 (5), 1118-1125, 2024 | | 2024 |
| 972. Imipenem-Cilastatin-Relebactam (I/R) Pharmacokinetics (PK) in Critically Ill Patients Supported on Extracorporeal Membrane Oxygenation (ECMO) AJ Fratoni, A Kois, JA Gluck, DP Nicolau, JL Kuti Open Forum Infectious Diseases 10 (Supplement_2), ofad500. 027, 2023 | | 2023 |
| In vitro activity of imipenem/relebactam against Pseudomonas aeruginosa isolated from patients with cystic fibrosis VH Ruiz, A Fratoni, DP Nicolau, JL Kuti Antimicrobial Agents and Chemotherapy 67 (11), e00920-23, 2023 | | 2023 |
| 1722. In vivo Activity of Imipenem/XNW4107 Human-Simulated Regimen against Serine Carbapenemase-Producing Acinetobacter baumannii and Pseudomonas aeruginosa in the Neutropenic … AJ Fratoni, A Berry, H Yuan, X Liu, X Chen, Y Wu, DP Nicolau, ... Open Forum Infectious Diseases 9 (Supplement_2), ofac492. 1352, 2022 | | 2022 |
| 626. Tebipenem Pharmacokinetics and Soft-Tissue Distribution in Diabetic Patients with Lower Extremity Infections using In Vivo Microdialysis Y Abouelhassan, AJ Fratoni, A Shepard, DP Nicolau, TE Asempa Open Forum Infectious Diseases 9 (Supplement_2), ofac492. 678, 2022 | | 2022 |
